Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
5
References
4
Citations
NaN
KQI